Harm Reduction - Archive
Access the current page here
The ASH Archive contains information that is no longer current but is useful reference material. The information is held in a separate archive of each page.
Documents in the Archives can be accessed by a link on each page or by the ASH Archives page or by using the advanced search.
For details on Use/Copyright please read the ASH Archives page.
Harm reduction seminar: European Respiratory Society (External Web Page)
A research seminar in which the case is made for a regulatory system encompassing all nicotine products.
The lessons of light and low tar cigarettes
Without effective regulation, 'reduced risk' tobacco products threaten public health. Report by the US House of Representatives
Health effects associated with smokeless tobacco: a systematic review
Article in Thorax of a systematic review of studies relating the smokeless tobacco.
EU policy on smokeless tobacco: a statement in favour of evidence-based regulation for public health
The report outlines the case for lifting the ban on certain types of oral tobacco in the European Union. The European Union denies smokers to other tobacco options available to them.
Snuffing, smoking and the risk for heart disease and other vascular diseases
The impact of smokeless tobacco use on smoking in northern Sweden. A review done for ASH.Harm reduction seminar: ASH background information
Background paper on issues and conflicts over harm reduction strategies for tobacco. The product is harm reducing if lower total tobacco related morbidity and mortality even though that product may involve continued exposure to tobacco related toxicants.Harm Reduction Seminar
Held by the Health Development Agency (from 2005 called the National Institute of Clinical Excellence), ASH and Pharmacy Healthcare Scheme at the Russell Hotel. The aim of the meeting was to discuss the role that a harm reduction strategy can play in tobacco control.
Chronic Disease Mortality in a Cohort of Smokeless Tobacco Users
The purpose of this study was to characterize the relation between smokeless tobacco use and the risk of all-cause and disease-specific mortality. The authors assessed the 20-year mortality experience of smokeless tobacco users.
Tobacco harm reduction: a framework
Conceptual structure and nomenclature for analysis and research.
The goal of tobacco control has always been to reduce death and disease due to tobacco use. Recent discussions have broadened the concept of tobacco control beyond cessation and prevention to include concepts such as the use of medications to achieve reduction in tobacco use, chemoprevention to reduce disease, modifications of tobacco products to reduce toxicity, and behavioural approaches to change smoking and tobacco use behaviour.
New Scientist: My friend Nicotine (External Web Page)
Feature in the New Scientist on tobacco harm reduction. 10 November 2001 by Clair Wilson
New Scientist: Can't quit, wont quit (External Web Page)
Editoral in the New Scientist on harm reduction. 10 November 2001.
Harm reduction, public health and human rights.
Smokers have a right to be informed of significant harm reduction options
Public health policy needs to be assessed for effects on human rights as well as public health. Although promoting harm reduction products to cigarette smokers might lead to greater total public health harm, if the products become too popular, human rights issues also need to be considered.
ASH's critique of the US Institute of Medicine report
ASH's critique of the US Institute of Medicine (IOM) report published as an editorial in the Tobacco Control Journal (June 2001).
Institute of Medicine: Clearing the smoke (External Web Page)
Report by the US Institute of Medicine (IOM). Clearing the Smoke: Assessing the science base for tobacco harm reduction. A vast report of what causes harm in tobacco products and what might be done about it. Feb 2001.
